The first clinical trial in the United States of a new form of immunotherapy for type 1 diabetes showed no serious side effects after the administration of up to 2.6 billion T-cells protecting the pancreas. 28 November 2017, 03:05 (NeBoley.com.ua)
You can vote until March 29. 26 March 2026, 22:49 (Зеркало недели)
Stress encourages behaviors that may cause cancer. Today, 12:41 (Обозреватель)